Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

SURF’n Autoinflammation: Evaluation & Management of Syndrome of Undifferentiated Recurrent Fever

Samantha C. Shapiro, MD  |  November 23, 2024

WASHINGTON, D.C.—It’s an exciting time in the field of autoinflammation, but it’s still fairly new at almost 30 years old. Researchers are still discovering new autoinflammatory diseases (AIDs) with both monogenic and polygenic multifactorial causes.

At the ACR Convergence 2024 session SURF’n Autoinflammation—Evaluation and Management of Syndrome of Undifferentiated Recurrent Fever, Lori Broderick, MD, PhD, director, Recurrent Fever Disorders Clinic, Rady Children’s Hospital-San Diego, and associate professor of pediatrics, Division of Allergy, Immunology, Rheumatology and Kawasaki Disease, University of California San Diego (UCSD), La Jolla, Calif., shared work from her clinic that led to the new classification of an emerging entity in this space: syndrome of undifferentiated recurrent fever (SURF).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

From Monogenic to Polygenic & Multifactorial

Dr. Broderick

Dr. Broderick

The identification of named AIDs represents true bench-to-bedside medicine. “Autoinflammatory disease identification is driven by patients—the ones constantly coming back to the clinic that you’re just looking for a diagnosis for,” Dr. Broderick explained.

As a pediatric allergy/immunologist, Dr. Broderick thinks about immune dysregulation from a different perspective than most of us do as rheumatologists. Immune dysregulation can fall into multiple categories, ranging from immunodeficiency and atopic disease, to autoimmunity, hyperinflammation, auto-inflammation and dysimmunopoiesis (i.e., primary failure or expansion of “immune” cells, like lymphoma and myelofibrosis).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Over the past 30 years, more than 40 different monogenic disorders have been defined in the autoinflammatory space. Dr. Broderick pointed to a 2020 review of monogenic autoinflammatory disorders by rheumatologist Peter A. Nigrovic, MD, and colleagues that summarizes them particularly well.1 “This is one of the best reviews on the topic. No matter how the patient presents to you in clinic, you may be able to find the correct diagnosis in the chart in this paper,” she said.

However, we are now moving away from the monogenic, autosomal dominant and autosomal recessive AIDs into things that are a bit more common—the polygenic and multifactorial diseases. However, Dr. Broderick explained, “The challenging aspect about these diseases is that the phenotypes might not be as extreme as the monogenic disorders.” These patients’ symptoms may not be as striking, but they’re prominent enough to disrupt the daily life. “My child is sick all the time” is a common refrain heard in her clinic.

“My Child is Sick all the Time”

In the past few years, the Recurrent Fever Disorders Clinic at UCSD—Rady Children’s Hospital has grown exponentially, and Dr. Broderick and colleagues are seeing more and more patients that don’t fit into any known AID categories. Many patients are being referred given concern for periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:ACR Convergence 2024ColchicinePeriodic fever syndromesPFAPA

Related Articles

    Colchicine: An Ancient Drug with Modern Uses

    August 11, 2021

    Discovered more than 3,000 years ago, colchicine is one of the oldest drugs still in use today. Like most old remedies, colchicine is a chemical substance found in many plants, most notably in colchicum autumnale, known as wild saffron or autumn crocus. It was mentioned in the oldest Egyptian medical text, Ebers Papyrus (circa 1550…

    Mattew - Bilder und mehr / shutterstock.com

    Yao Syndrome: A Case Report & Clinical Review

    November 12, 2020

    Case Presentation History of present illness A 66-year-old white woman presented with unexplained, recurrent episodes of high fever, abdominal pain, rash and arthralgias occurring over the previous three years. During typical episodes, the patient experienced flu-like symptoms, followed by fever, abdominal pain and non-bloody diarrhea without tenesmus. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEHer temperatures were 101–103ºF,…

    Management Updates for a Spectrum of Systemic Autoinflammatory Diseases

    January 19, 2024

    SAN DIEGO—As part of a panel on systemic autoinflammatory diseases (SAIDs) at a Nov. 15 scientific session of ACR Convergence 2023, Sivia Lapidus, MD, shared context and insights on the therapeutic management of patients with these conditions. The Spectrum of SAIDs SAIDs encompass a broad swath of individually rare disorders driven by innate immune responses…

    Nature’s Inflammation Experiment

    August 1, 2008

    Familial Mediterranean fever a frequently misdiagnosed autoinflammatory disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences